Zealand Pharma A/S. OverviewZealand Pharma A/S. Research & Development
Research & Development expenses for ZEAL.
Quarterly R&D Expenses
$152.53M
As of Mar 10, 2022
Annual R&D Expenses (TTM)
$599.69M
↓ 0.73% YoY
Trailing 12 months ending Mar 10, 2022